ArticleCureus2026
Prevalence of Anxiety and Depression in Patients With Pulmonary Hypertension and Their Impact on Health-Related Quality of Life: A Prospective Cross-Sectional Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Pulmonary hypertension (PH) is a chronic progressive disease that affects quality of life (QoL). The prevalence of mood disorders in PH patients in Saudi Arabia is not known. The aim of this study was to investigate the prevalence of anxiety and depression in patients with PH and to examine their association with health-related quality of life (HRQoL). Methods This was a prospective cross-sectional observational study. In this study, 42 PH patients were evaluated for mood disorders using the Hospital Anxiety and Depression Scale (HADS), and HRQoL was assessed using the Short Form 36 (SF-36) Health Survey. Results In the current study, 42 PH patients were evaluated. The cohort's mean age was 42.8±13.3 years, and 31 (74%) were women. Mean pulmonary artery pressure was 46.4±15 mm Hg, and 25 (60%) patients had severe PH (mean pulmonary artery pressure (mPAP)>45 mmHg). Thirty-eight (90%) patients were in World Health Organization Functional Class (WHO-FC) II/III, and four (10%) were in WHO-FC IV. HADS anxiety and depression scores were elevated (11-21) in four (10%) and six (14%) patients, respectively. The presence of anxiety and/or depression affected HRQoL. Conclusion Anxiety and depression were infrequent among PH patients. Further studies with formal psychosocial evaluation are needed to confirm these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.